Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Kalvista Pharmaceuticals Inc
KALVCurrent price
8.82 USD
+0.38 USD (+4.50%)
Last closed
8.44 USD
Company
www.kalvista.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
303 438 848 USD
Yield for 12 month
+70.60 %
Week
Month
Year
KALV
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with unmet needs in the United States. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include sebetralstat, which is initiation of the Phase 3 KONFIDENT trial as a potential oral, on-demand therapy for HAE attacks; and Factor XIIa, an oral inhibitor program which is in preclinical stage targets an enzyme in HAE. The company is headquartered in Cambridge, Massachusetts. Address: 55 Cambridge Parkway, Cambridge, MA, United States, 02142
Analytics
WallStreet Target Price
20.8 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures KALV
1 year
3 years
5 years
10 years
EBITDA
-97 114 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-35.7 %
PEG Ratio
–
Return On Equity TTM
-62.64 %
Wall Street Target Price
20.8 USD
Revenue TTM
3 824 000 USD
Book Value
4.07 USD
Revenue Per Share TTM
0.21 USD
Dividend Share
–
Quarterly Revenue Growth YOY
30.7 %
Dividend Yield
–
Gross Profit TTM
-80 276 000 USD
Earnings Share
-3.13 USD
Diluted Eps TTM
-3.13 USD
Most Recent Quarter
III 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics KALV
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History KALV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:14
Payout Ratio
–
Last Split Date
22.11.2016
Dividend Date
22.11.2016
Stock Valuation KALV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
76.3323
Price Sales TTM
107.4168
Enterprise Value EBITDA
-1.6668
Price Book MRQ
2.1778
Financials KALV
1 year
3 years
5 years
10 years
| Results | 2019 | Dynamics |
Technical indicators KALV
For 52 weeks
5 USD
11.45 USD
50 Day MA
8.67 USD
Shares Short Prior Month
4 139 810
200 Day MA
9.1 USD
Short Ratio
15.43
Shares Short
4 003 311
Short Percent
12.43 %
Google
Apple
Facebook